White matter hyperintensities in patients with multiple system atrophy

Parkinsonism and Related Disorders

Volumn 18, Issue 1, 2012, Pages 17-20

  Umoto, Maiko ^a   Miwa, Hideto ^a   Ando, Ryuki ^a   Kajimoto, Yoshinori ^a   Kondo, Tomoyoshi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Magnetic resonance imaging; Multiple system atrophy; Orthostatic hypotension; Parkinson's disease; White matter hyperintensities

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; URINE INCONTINENCE; WHITE MATTER; WHITE MATTER HYPERINTENSITIES;

AGE FACTORS; AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE FIBERS, MYELINATED;

EID: 84860419918     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.08.004     Document Type: Article

References (30)

1. Morris Z., Whiteley W.N., Longstreth W.T., Weber F., Lee Y.C., Tsushima Y., et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009, 339:b3016.
2. Young V.G., Halliday G.M., Kril J.J. Neuropathologic correlates of white matter hyperintensities. Neurology 2008, 71:804-811.
3. Gouw A.A., Seewann A., van der Flier W.M., Barkhof F., Rozemuller A.M., Scheltens P., et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. JNeurol Neurosurg Psychiatry 2011, 82:126-135.
4. Kalaria R.N. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 2002, 13(Suppl. 2):48-52.
5. Smith E.E., Greenberg S.M. Beta-amyloid, blood vessels, and brain function. Stroke 2009, 40(7):2601-2606.
6. Schmidt R., Schmidt H., Fazekas F. Vascular risk factors in dementia. JNeurol 2000, 247(2):81-87.
7. Knopman D.S., Roberts R. Vascular risk factors: imaging and neuropathologic correlates. JAlzheimers Dis 2010, 20(3):699-709.
8. Appel J., Potter E., Bhatia N., Shen Q., Zhao W., Greig M.T., et al. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol 2009, 30(10):1870-1876.
9. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., et al. Consensus statement on the diagnosis of multiple system atrophy. JNeurol Sci 1999, 163(1):94-98.
10. Schrag A., Geser F., Stampfer-Kountchev M., Seppi K., Sawires M., Köllensperger M., et al. Health-related quality of life in multiple system atrophy. Mov Disord 2006, 21(6):809-815.
11. van der Flier W.M., Barkhof F., Scheltens P. Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann N Y Acad Sci 2007, 1097:215-224.
12. Jellinger K.A., Attems J. Neuropathological evaluation of mixed dementia. JNeurol Sci 2007, 257(1-2):80-87.
13. Liao D., Cooper L., Cai J., Toole J.F., Bryan N.R., Hutchinson R.G., et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996, 27(12):2262-2270.
14. Yue N.C., Arnold A.M., Longstreth W.T., Elster A.D., Jungreis C.A., O'Leary D.H., et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology 1997, 202(1):33-39.
15. Lim T.S., Lee P.H., Kim H.S., Yong S.W. White matter hyperintensities in patients with multiple system atrophy. JNeurol 2009, 256(10):1663-1670.
16. de Leeuw F.E., de Groot J.C., Oudkerk M., Witteman J.C., Hofman A., van Gijn J., et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002, 125:765-772.
17. Murray A.D., Staff R.T., Shenkin S.D., Deary I.J., Starr J.M., Whalley L.J. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005, 237(1):251-257.
18. Chowdhury M.H., Nagai A., Bokura H., Nakamura E., Kobayashi S., Yamaguchi S. Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. JStroke Cerebrovasc Dis 2010, Jul 14. [Epub ahead of print].
19. Fazekas F., Niederkorn K., Schmidt R., Offenbacher H., Horner S., Bertha G., et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988, 19:1285-1288.
20. Kalaria R.N. Cerebral vessels in aging and Alzheimer's disease. Pharmacol Ther 1996, 72:163-214.
21. Greenberg S.M. Cerebral amyloid angiopathy and dementia: two amyloids are worse than one. Neurology 2002, 58(11):1587-1588.
22. Jefferson A.L., Tate D.F., Poppas A., Brickman A.M., Paul R.H., Gunstad J., et al. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. JAm Geriatr Soc 2007, 55(7):1044-1048.
23. Burn D.J., Jaros E. Multiple system atrophy: cellular and molecular pathology. Mol Pathol 2001, 54(6):419-426.
24. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996, 27:1641-1646.
25. Jokinen H., Kalska H., Mäntylä R., Ylikoski R., Hietanen M., Pohjasvaara T., et al. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. JNeurol Neurosurg Psychiatry 2005, 76(9):1229-1233.
26. van Straaten E.C., Harvey D., Scheltens P., Barkhof F., Petersen R.C., Thal L.J., et al. Alzheimer's Disease Cooperative Study Group. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. JNeurol 2008, 255(9):1302-1308.
27. Dalaker T.O., Larsen J.P., Bergsland N., Beyer M.K., Alves G., Dwyer M.G., et al. Brain atrophy and white matter hyperintensities in early Parkinson's disease. Mov Disord 2009, 24(15):2233-2241.
28. Lee S.J., Kim J.S., Yoo J.Y., Song I.U., Kim B.S., Jung S.L., et al. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord 2010, 24(3):227-233.
29. Poewe W. Dysautonomia and cognitive dysfunction in Parkinson's disease. Mov Disord 2007, 22(Suppl. 17):S374-S378.
30. Scigliano G., Ronchetti G., Girotti F., Musicco M. Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease. Parkinsonism Relat Disord 2009, 15:138-143.